Guardian Pharmacy Services, Inc.
For the period ended Jun 30, 2025. Filed Aug 11, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 11, 2025
GRDN$47.02+10.9%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations
| Three Months Ended June 30, | Six Months Ended June 30, | |||
|---|---|---|---|---|
| (In thousands, except share and per share amounts) | 2024 | 2025 | 2024 | 2025 |
| Revenues | $300,037 | $344,334 | $575,447 | $673,642 |
| Cost of goods sold | 238,749 | 276,188 | 459,058 | 541,147 |
| Gross profit | 61,288 | 68,146 | 116,389 | 132,495 |
| Selling, general, and administrative expenses | 44,283 | 55,566 | 91,451 | 106,910 |
| Operating income | 17,005 | 12,580 | 24,938 | 25,585 |
| Other expenses (income): | ||||
| Interest expense | 1,066 | 172 | 1,831 | 342 |
| Other expense (income), net | 91 | (179) | 164 | (450) |
| Total other expenses (income) | 1,157 | (7) | 1,995 | (108) |
| Income before income taxes | 15,848 | 12,587 | 22,943 | 25,693 |
| Provision for income taxes | — | 3,760 | — | 7,593 |
| Net income | 15,848 | 8,827 | 22,943 | 18,100 |
| Less net income attributable to Guardian Pharmacy, LLC prior to the Corporate Reorganization | 10,624 | — | 13,410 | — |
| Less net income (loss) attributable to non-controlling interests | 5,224 | (203) | 9,533 | (378) |
| Net income attributable to Guardian Pharmacy Services, Inc. | $— | $9,030 | $— | $18,478 |
| Basic | N/A | $0.15 | N/A | $0.30 |
| Diluted | N/A | $0.14 | N/A | $0.29 |
| Weighted-average Class A and Class B common shares outstanding | ||||
| Basic | N/A | 62,045,901 | N/A | 62,044,614 |
| Diluted | N/A | 63,203,003 | N/A | 63,055,106 |
| 1 | Basic and diluted net income per share of Class A and Class B common stock is applicable only for the three and six months ended June 30, 2025, which are the only periods presented following the initial public offering (“IPO”) and related Corporate Reorganization (as defined below in Note 1 Organization and Background). See Note 6 Basic and Diluted Net Income Per Share for the number of shares used in the computation of net income per share of Class A and Class B common stock and the basis for the computation of net income per share. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.